OneMedNet Corp Income Statement
ONMD|3 years of annual SEC 10-K data (FY2023-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 3 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Revenue
$643,000
FY2025
Gross Profit
-$281,000
-43.7% gross margin
Operating Income
-$10M
FY2025
Net Income
-$10M
FY2025
OneMedNet Corp reported $643,000 in revenue and $10M in net loss for FY2025. Revenue has declined at a 25.3% compound annual rate over the past 2 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Negative shareholders equity: Liabilities exceed assets
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $643.0K | $1.0M | $1.2M |
| Cost of Revenue | $924.0K | $1.1M | $1.5M |
| Gross Profit | -$281.0K | -$129.0K | -$360.7K |
| SG&A Expense | $7.0M | $3.5M | $8.8M |
| R&D Expense | $1.5M | $2.1M | $952.7K |
| Operating Income | -$9.6M | -$6.9M | -$11.4M |
| Interest Expense | - | - | $403.3K |
| Income Tax | $2.0K | $18.0K | $214.8K |
| Net Income | -$10.1M | -$33.8M | -$6.2M |
| EPS (Basic) | -$0.36 | -$4.65 | -$0.98 |
| EPS (Diluted) | -$0.36 | -$4.65 | -$0.98 |
| Shares Outstanding | 28.0M | 23.6M | 4.0M |
| Gross Margin | -43.7% | -12.6% | -31.3% |
| Operating Margin | -1493.8% | -671.2% | -991.2% |
| Profit Margin | -1575.3% | -3308.5% | -540.4% |